fluoxetine has been researched along with 1-anilino-8-naphthalenesulfonate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS | 1 |
Curti, C; Galastri, LO; Mingatto, FE; Polizello, AC; Santos, AC; Uyemura, SA | 1 |
Kanitra, L; Moore, R; Mulligan, TE; Zhi, J | 1 |
Li, Z; Maggard, M; Maglione, M; Mojica, WA; Morton, SC; Shekelle, PG; Shugarman, L; Solomon, V; Suttorp, M; Tu, W | 1 |
Chen, YW; Chiu, YJ; Kung, ML; Tu, HH; Wu, HJ | 1 |
2 review(s) available for fluoxetine and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
Challenges in obesity management.
Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline | 1998 |
Pharmacological and surgical treatment of obesity.
Topics: Adult; Appetite Depressants; Bupropion; Cyclobutanes; Diethylpropion; Fluoxetine; Fructose; Gastric Bypass; Gastroplasty; Humans; Lactones; Lipase; Obesity; Orlistat; Phentermine; Topiramate | 2004 |
1 trial(s) available for fluoxetine and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Area Under Curve; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Hypolipidemic Agents; Lactones; Lipase; Male; Middle Aged; Orlistat; Simvastatin | 2003 |
2 other study(ies) available for fluoxetine and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity.
Topics: Adenosine Triphosphate; Anilino Naphthalenesulfonates; Animals; Antidepressive Agents, Second-Generation; Brain; Cell Respiration; Fluorescent Dyes; Fluoxetine; In Vitro Techniques; Intracellular Membranes; Kinetics; Lipid Bilayers; Male; Mitochondria; Oxygen Consumption; Phosphorylation; Proton-Translocating ATPases; Rats; Rats, Wistar | 1999 |
Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, White; Animals; Behavior, Animal; Depression; Diet, High-Fat; Fluoxetine; Glucose; Glucose Tolerance Test; Injections, Intraperitoneal; Lipase; Lipolysis; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; PPAR gamma; Selective Serotonin Reuptake Inhibitors | 2021 |